Literature DB >> 16695990

Ki67: from antibody to molecule to understanding?

W Ross1, P A Hall.   

Abstract

Year:  1995        PMID： 16695990      PMCID： PMC407942          DOI： 10.1136/mp.48.3.m113

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN： 1355-2910


× No keyword cloud information.
  25 in total

1.  Chromosomal passengers: toward an integrated view of mitosis.

Authors:  W C Earnshaw; R L Bernat
Journal:  Chromosoma       Date:  1991-03       Impact factor: 4.316

Review 2.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.

Authors:  J H van Dierendonck; R Keijzer; C J van de Velde; C J Cornelisse
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

4.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody.

Authors:  B Falini; L Flenghi; M Fagioli; H Stein; R Schwarting; C Riccardi; I Manocchio; S Pileri; P G Pelicci; L Lanfrancone
Journal:  J Histochem Cytochem       Date:  1989-10       Impact factor: 2.479

7.  The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; M A Richards; W M Gregory; A J d'Ardenne; T A Lister; A G Stansfeld
Journal:  J Pathol       Date:  1988-03       Impact factor: 7.996

Review 8.  The nuclear matrix: structure and composition.

Authors:  R Verheijen; W van Venrooij; F Ramaekers
Journal:  J Cell Sci       Date:  1988-05       Impact factor: 5.285

9.  Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes.

Authors:  R Verheijen; H J Kuijpers; R van Driel; J L Beck; J H van Dierendonck; G J Brakenhoff; F C Ramaekers
Journal:  J Cell Sci       Date:  1989-04       Impact factor: 5.285

10.  Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase.

Authors:  R Verheijen; H J Kuijpers; R O Schlingemann; A L Boehmer; R van Driel; G J Brakenhoff; F C Ramaekers
Journal:  J Cell Sci       Date:  1989-01       Impact factor: 5.285
View more
  18 in total

1.  Non-proliferative capacity of endocrine cells of the human gastro-intestinal tract.

Authors:  H L Waldum; E Brenna
Journal:  Histochem J       Date:  1996-05

2.  Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.

Authors:  Devon S Chabot-Richards; David R Martin; Orrin B Myers; David R Czuchlewski; Kristin E Hunt
Journal:  Mod Pathol       Date:  2011-08-12       Impact factor: 7.842

3.  Cell kinetic analysis in recurrent neuro-epithelial tumours.

Authors:  E Gömöri; I Mészáros; G Méhes; T Dóczi; L Pajor
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

4.  StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.

Authors:  John M Centanni; Joely A Straseski; April Wicks; Jacquelyn A Hank; Cathy A Rasmussen; Mary A Lokuta; Michael J Schurr; Kevin N Foster; Lee D Faucher; Daniel M Caruso; Allen R Comer; B Lynn Allen-Hoffmann
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

5.  KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.

Authors:  Lynn M Hassman; Thomas J Ellison; Dean H Kedes
Journal:  J Clin Invest       Date:  2011-01-18       Impact factor: 14.808

6.  Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node.

Authors:  David R Fooksman; Michel C Nussenzweig; Michael L Dustin
Journal:  J Immunol       Date:  2013-12-27       Impact factor: 5.422

7.  The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities.

Authors:  Eun-Kyoung Yim Breuer; Mandi M Murph
Journal:  Int J Proteomics       Date:  2011-01-01

8.  Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat.

Authors:  B Xie; N N Tam; S W Tsao; Y C Wong
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  Studies of ribonucleotide reductase in crucian carp-an oxygen dependent enzyme in an anoxia tolerant vertebrate.

Authors:  Guro K Sandvik; Ane B Tomter; Jonas Bergan; Giorgio Zoppellaro; Anne-Laure Barra; Asmund K Røhr; Matthias Kolberg; Stian Ellefsen; K Kristoffer Andersson; Göran E Nilsson
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

10.  Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients.

Authors:  Jun Li; Sile Han; Cuiyun Zhang; Yanlin Luo; Li Wang; Ping Wang; Yi Wang; Qingxin Xia; Xiaoyan Wang; Bing Wei; Jie Ma; Hongle Li; Yongjun Guo
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.